Literature DB >> 3840028

Clinically significant sucralfate-warfarin interaction is not likely.

P J Neuvonen, A Jaakkola, J Tötterman, O Penttilä.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3840028      PMCID： PMC1400679          DOI： 10.1111/j.1365-2125.1985.tb05056.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.

Authors:  P A OWREN; K AAS
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

2.  Interaction of warfarin and nonsystemic gastrointestinal drugs.

Authors:  D S Robinson; D M Benjamin; J J McCormack
Journal:  Clin Pharmacol Ther       Date:  1971 May-Jun       Impact factor: 6.875

Review 3.  Drug interactions with warfarin.

Authors:  M J Serlin; A M Breckenridge
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

4.  Rapid, reliable and sensitive assay for warfarin using normal-phase high-performance liquid chromatography.

Authors:  R A Tasker; K Nakatsu
Journal:  J Chromatogr       Date:  1982-03-12

Review 5.  Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546
  5 in total
  3 in total

Review 1.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

Review 2.  North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management angina. North of England Stable Angina Guideline Development Group.

Authors: 
Journal:  BMJ       Date:  1996-03-30

Review 3.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.